Denise Boudreau

Summary

Affiliation: Group Health Cooperative
Country: USA

Publications

  1. pmc Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA, 98101, USA
    Breast Cancer Res Treat 144:405-16. 2014
  2. pmc Influence of body mass index on the choice of therapy for depression and follow-up care
    Denise M Boudreau
    Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA
    Obesity (Silver Spring) 21:E303-13. 2013
  3. doi request reprint A survey of adult awareness and use of medicine containing acetaminophen
    Denise M Boudreau
    Group Health Research Institute, Seattle, WA 98101, USA
    Pharmacoepidemiol Drug Saf 22:229-40. 2013
  4. doi request reprint Accuracy of ICD-9 codes to identify nonunion and malunion and developing algorithms to improve case-finding of nonunion and malunion
    Denise M Boudreau
    Group Health Research Institute, Seattle, WA 98101, USA
    Bone 52:596-601. 2013
  5. pmc Statin use and breast cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 16:416-21. 2007
  6. pmc Concordance of population-based estimates of mammography screening
    Denise M Boudreau
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    Prev Med 45:262-6. 2007
  7. pmc Statin use and prostate cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 19:767-74. 2008
  8. pmc Cardiovascular medication use and risk for colorectal cancer
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 17:3076-80. 2008
  9. pmc Trends in long-term opioid therapy for chronic non-cancer pain
    Denise Boudreau
    Group Health Center for Health Studies, 1730 Minor Avenue, Seattle, WA 98101, USA
    Pharmacoepidemiol Drug Saf 18:1166-75. 2009
  10. pmc Statin use and cancer risk: a comprehensive review
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Expert Opin Drug Saf 9:603-21. 2010

Research Grants

  1. Satin Use and the Risk of Site Specific Cancers
    Denise Boudreau; Fiscal Year: 2005
  2. Medication and Colorectal Cancer Risk
    Denise Boudreau; Fiscal Year: 2005
  3. Commonly Used Medications and Breast Cancer Recurrence
    Denise Boudreau; Fiscal Year: 2007
  4. Commonly Used Medications and Breast Cancer Recurrence
    Denise Boudreau; Fiscal Year: 2009
  5. Commonly Used Medications and Breast Cancer Recurrence
    Denise M Boudreau; Fiscal Year: 2010
  6. Commonly Used Medications and Breast Cancer Recurrence
    Denise Boudreau; Fiscal Year: 2009

Detail Information

Publications27

  1. pmc Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA, 98101, USA
    Breast Cancer Res Treat 144:405-16. 2014
    ..A majority of CVD medications evaluated in this study appear safe with respect to SBCE, but ACEI and BB use warrant further evaluation. The study presented is one example of the questions that can be addressed using the COMBO cohort...
  2. pmc Influence of body mass index on the choice of therapy for depression and follow-up care
    Denise M Boudreau
    Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA
    Obesity (Silver Spring) 21:E303-13. 2013
    ..We conducted a cohort study to investigate whether obesity is associated with treatment choices for depression; and whether obesity is associated with appropriate duration of depression treatment and receipt of follow-up visits...
  3. doi request reprint A survey of adult awareness and use of medicine containing acetaminophen
    Denise M Boudreau
    Group Health Research Institute, Seattle, WA 98101, USA
    Pharmacoepidemiol Drug Saf 22:229-40. 2013
    ..To compare awareness, use of acetaminophen, and preferences for receiving information aimed at reducing acetaminophen overdose...
  4. doi request reprint Accuracy of ICD-9 codes to identify nonunion and malunion and developing algorithms to improve case-finding of nonunion and malunion
    Denise M Boudreau
    Group Health Research Institute, Seattle, WA 98101, USA
    Bone 52:596-601. 2013
    ..To evaluate the accuracy of using ICD-9 codes to identify nonunions (NU) and malunions (MU) among adults with a prior fracture code and to explore case-finding algorithms...
  5. pmc Statin use and breast cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 16:416-21. 2007
    ..Mechanistic studies suggest that 3-hydroxy-3-methylglutaryl CoA inhibitors (statins) reduce the risk of breast cancer. Observational studies offer mixed results...
  6. pmc Concordance of population-based estimates of mammography screening
    Denise M Boudreau
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    Prev Med 45:262-6. 2007
    ..This study estimated adherence to repeat (two successive on-time screenings) and regular screening (three or more successive screenings) and evaluated the impact of varying operational definitions and evaluation periods...
  7. pmc Statin use and prostate cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 19:767-74. 2008
    ..Statins are a commonly used cholesterol-lowering drug, which also have the potential to affect cancer risk and progression. Results from previous studies offer mixed conclusions...
  8. pmc Cardiovascular medication use and risk for colorectal cancer
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 17:3076-80. 2008
    ..We hypothesized a reduction in colorectal cancer risk with 3-hydroxy-3-methylglutaryl coA reductase inhibitors (statins) and angiotensin-converting enzyme inhibitors...
  9. pmc Trends in long-term opioid therapy for chronic non-cancer pain
    Denise Boudreau
    Group Health Center for Health Studies, 1730 Minor Avenue, Seattle, WA 98101, USA
    Pharmacoepidemiol Drug Saf 18:1166-75. 2009
    ..To report trends and characteristics of long-term opioid use for non-cancer pain...
  10. pmc Statin use and cancer risk: a comprehensive review
    Denise M Boudreau
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Expert Opin Drug Saf 9:603-21. 2010
    ..They are among the most commonly prescribed drugs worldwide. Contrary to early concerns over the carcinogenicity of statins, a growing body of evidence suggests statins may in fact have a chemopreventive potential against cancer...
  11. pmc The influence of statin use on breast density
    Denise M Boudreau
    Group Health Cooperative, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 15:1026-9. 2006
    ..To evaluate if 3-hydroxy-3-methylglutaryl CoA reductase reductase inhibitor use (statins) alters mammography measured breast density...
  12. ncbi request reprint Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101 1448, USA
    Med Care 44:62-9. 2006
    ..We sought to evaluate the effects of hormone therapy (HT) on false-positive (FP) recall for additional breast evaluation and costs...
  13. ncbi request reprint The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Cancer 100:2308-16. 2004
    ..However, statins have been found to be carcinogenic in rodents and one clinical trial found an excess of breast carcinoma cases in the treatment group...
  14. ncbi request reprint Risks for frequent antimicrobial-treated infections in postmenopausal women
    Denise M Boudreau
    School of Pharmacy, University of Washington, Seattle, Washington, USA
    Aging Clin Exp Res 15:12-8. 2003
    ..This study in postmenopausal women examines health-related conditions and behavioral factors that may increase the risk of frequent infections, defined as having, on average, one or more infections per year...
  15. ncbi request reprint A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Am J Epidemiol 159:308-17. 2004
    ..Trivial changes in estimates were observed when health maintenance organization records alone were used as the gold standard. Self-reported use of antihypertensives and statins appears to be relatively accurate among older women...
  16. doi request reprint Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA, USA
    J Am Geriatr Soc 59:2069-76. 2011
    ..To determine the extent of concomitant use of cholinesterase inhibitor (ChI) and anticholinergic (ACh) medications and the clinical consequences of dual use in a population-based setting...
  17. pmc De facto long-term opioid therapy for noncancer pain
    Michael Von Korff
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Clin J Pain 24:521-7. 2008
    ..This paper describes characteristics of opioid use episodes for noncancer pain and defines thresholds for de facto long-term opioid therapy...
  18. ncbi request reprint Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years
    Christopher I Li
    Public Health Sciences Division, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Cancer 98:1504-13. 2003
    ....
  19. ncbi request reprint Antidepressant use and breast cancer risk
    Chloe Chien
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Breast Cancer Res Treat 95:131-40. 2006
    ..However, human studies evaluating use of antidepressants in relation to breast cancer risk have yielded inconsistent results...
  20. doi request reprint Quality of life valuations of mammography screening
    Amy E Bonomi
    Human Development and Family Science, The Ohio State University, 135 Campbell Hall, 1787 Neil Avenue, Columbus, OH 43210, USA
    Qual Life Res 17:801-14. 2008
    ..To obtain quality-of-life (QOL) valuations associated with mammography screening and breast cancer treatment that are suitable for use in cost-effectiveness analyses...
  21. ncbi request reprint Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis
    Amy E Bonomi
    Puget Sound Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue, Suite 1600 Seattle, WA 98101 2903, USA
    Qual Life Res 14:1127-33. 2005
    ..Using the health plan as a working frame of reference, we explore conceptual issues related to estimating effectiveness at the level of the family for use in CEA...
  22. ncbi request reprint Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications
    Denise M Boudreau
    Ann Pharmacother 38:1317-8. 2004
  23. ncbi request reprint Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care
    Kam L Capoccia
    Departments of Pharmacy and Family Medicine, University of Washington, Seattle, USA
    Am J Health Syst Pharm 61:364-72. 2004
    ..The impact of pharmacist interventions on the care and outcomes of patients with depression in a primary care setting was evaluated...
  24. doi request reprint Administrative data used to identify patients with irritable bowel syndrome
    Sarah L Goff
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation and Fallon Community Health Plan, 630 Plantation Street, Worcester, MA 01605, USA
    J Clin Epidemiol 61:617-21. 2008
    ..To assess the usefulness of health plan administrative data for identifying patients with irritable bowel syndrome (IBS)...
  25. ncbi request reprint Re: "studies with low response proportions may be less biased than studies with high response proportions"
    Lynda F Voigt
    Am J Epidemiol 161:401-2; author reply 402-3. 2005
  26. ncbi request reprint Reliability of Group Health Cooperative automated pharmacy data by drug benefit status
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101 1448, USA
    Pharmacoepidemiol Drug Saf 14:877-84. 2005
    ..Evaluate the reliability of health plan pharmacy records in determining medication use among seniors with and without a drug benefit...
  27. ncbi request reprint Collaborative care model to improve outcomes in major depression
    Denise M Boudreau
    Department of Pharmacy, University of Washington, Seattle, WA 98195 7630, USA
    Ann Pharmacother 36:585-91. 2002
    ..To develop a pharmacist intervention to improve depression care and outcomes within a primary care setting...

Research Grants7

  1. Satin Use and the Risk of Site Specific Cancers
    Denise Boudreau; Fiscal Year: 2005
    ..abstract_text> ..
  2. Medication and Colorectal Cancer Risk
    Denise Boudreau; Fiscal Year: 2005
    ..abstract_text> ..
  3. Commonly Used Medications and Breast Cancer Recurrence
    Denise Boudreau; Fiscal Year: 2007
    ..Learning more about whether there are factors that influence recurrence will help us with the secondary prevention of breast cancer and will lead to a reduction in breast cancer morbidity and mortality. ..
  4. Commonly Used Medications and Breast Cancer Recurrence
    Denise Boudreau; Fiscal Year: 2009
    ..Learning more about whether there are factors that influence recurrence will help us with the secondary prevention of breast cancer and will lead to a reduction in breast cancer morbidity and mortality. ..
  5. Commonly Used Medications and Breast Cancer Recurrence
    Denise M Boudreau; Fiscal Year: 2010
    ..Learning more about whether there are factors that influence recurrence will help us with the secondary prevention of breast cancer and will lead to a reduction in breast cancer morbidity and mortality. ..
  6. Commonly Used Medications and Breast Cancer Recurrence
    Denise Boudreau; Fiscal Year: 2009
    ..Learning more about whether there are factors that influence recurrence will help us with the secondary prevention of breast cancer and will lead to a reduction in breast cancer morbidity and mortality. ..